Faculty profile

Cheng-Han Lee

Back to faculty

Associate ProfessorLaboratory Medicine & Pathology DeptUniversity of Alberta

Cheng-Han Lee

Associate Professor

Laboratory Medicine & Pathology Dept

Faculty of Medicine & Dentistry

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
38 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Supervisor on 1 trainee award (1 CIHR), most recently in 2016.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

2,871

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Alberta profile.

Latest papers

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.
Current oncology (Toronto, Ont.) · 2026
Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.
Signal transduction and targeted therapy · 2026
Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.
The Journal of pathology · 2026 · senior author

All 75 publications

Latest funding

Dissecting and targeting SWI/SNF loss in de-differentiated endometrial carcinomas
CIHR · 2020 · Co-investigator
$1,078,650
Linking Inactivating Mutations in Chromatin Remodeling Complex Subunits to Aggressive Dedifferentiated Endometrial Carcinoma
CIHR · 2016 · Supervisor
$105,000
Translational research centre to target and characterize normal and cancer stem cell niches
CFI · 2013 · Co-investigator
$190,098

All 3 grants and awards

75 publications.

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.

Ma K, Tessier-Cloutier B, Altman AD, Carey MS, Ethier JL, Lau S, Lee CH, Hopkins L, Kieser K, Kumar A, Leung SOA, Nguyen JMV, MacKay H, McGee J, Salman L, Salvador S, Sluce C, Tatar L, Tone AA, Tinker A, Tremblay E, Veneziani AC, Vicus D, Welch S, Windsor Harker S, Brodeur MN

Current oncology (Toronto, Ont.)2026Open Access

DOI: 10.3390/curroncol33060330 PMID: 42346230

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

Price JDW, Vizeacoumar FS, Abuhussein O, Maranda V, Zhang Y, Adachi H, Nguyen K, Kyrylenko L, Rangel-Pozzo A, Dong H, Gong L, Materi A, Walke P, Ganapathysamy A, Denomy C, Freywald T, Dahiya R, Elhasasna H, Saxena A, Vizeacoumar JP, Patel H, Rajamanickam K, de Oliveira DM, Lazell-Wright M, Morales AM, Aggarwal A, Xu JL, Alli N, Munhoz EP, Gao P, Salsman J, Dahiya DK, Kola NS, Gonzalez-Lopez C, Thibault P, Levin M, Dellaire G, Jette N, Groot G, Köbel M, Lee CH, Hopkins L, Krishnan A, Ahmed S, Eskiw C, Barakat KH, Thakur A, Wu Y, DePinho RA, Mai S, Yu YT, Wong JMY, Freywald A, Vizeacoumar FJ

Signal transduction and targeted therapy2026Open Access

DOI: 10.1038/s41392-026-02750-0 PMID: 42236690

Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.

De Leo A, Wickenberg M, Grillini M, Coadǎ CA, Praveen Kumar P, Tong A, Key J, Kim H, Kommoss F, Carey M, Fu Y, Ceccarelli C, Tallini G, LaPointe P, Köbel M, Lee CH

The Journal of pathology2026Senior authorOpen Access

DOI: 10.1002/path.70102 PMID: 42535334

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Zwimpfer TA, Fereday S, Pandey A, Ariyaratne D, Jayawardana MW, Twomey L, Laumont CM, Kennedy CJ, Bolithon A, Meagher NS, Milne K, Hamilton P, Alsop J, Antoniou AC, Au-Yeung G, Beckmann MW, Berrington de Gonzalez A, Bisinotto C, Blome F, Bodelon C, Boros J, Brand AH, Carney ME, Cazorla-Jiménez A, Chiu DS, Christie EL, Chudecka-Głaz A, Coulson P, Cushing-Haugen KL, Cybulski C, Darcy KM, David C, Davidson T, Ekici AB, Elishaev E, Emons J, Engler T, Farrell R, Fischer A, García-Closas M, Gentry-Maharaj A, Ghatage P, Glasspool R, Harter P, Hartkopf AD, Hartmann A, Heikaus S, Hernandez BY, Hettiaratchi A, Heublein S, Huntsman DG, Jimenez-Linan M, Jones ME, Kang E, Kaznowska E, Kluz T, Kommoss FKF, Konecny G, Kruitwagen RFPM, Kwon J, Lambrechts D, Lee CH, Lester J, Leung SCY, Leung Y, Linder A, Lissowska J, Loverix L, Lubiński J, Mateoiu C, McNeish IA, Moubarak M, Nelson GS, Nevins N, Olawaiye AB, Olbrecht S, Orsulic S, Osorio A, Quinn CM, Mohan GR, Ray-Coquard I, Rodríguez-Antona C, Roxburgh P, Ruebner M, Salfinger SG, Samra S, Schoemaker MJ, Sinn HP, Sonke GS, Steele L, Stewart CJR, Talhouk A, Tan A, Tarney CM, Taylor SE, Van de Vijver KK, van der Aa MA, Van Gorp T, Van Nieuwenhuysen E, Van-Wagensveld L, Wahner-Hendrickson AE, Walter C, Wang C, Welz J, Wentzensen N, Wilkens LR, Winham SJ, Winterhoff B, Anglesio MS, Berchuck A, Candido Dos Reis FJ, Cohen PA, Conrads TP, Crowe P, Doherty JA, Fasching PA, Fortner RT, García MJ, Gayther SA, Goodman MT, Gronwald J, Harris HR, Heitz F, Horlings HM, Karlan BY, Kelemen LE, Larry Maxwell G, Menon U, Modugno F, Neuhausen SL, Schildkraut JM, Staebler A, Sundfeldt K, Swerdlow AJ, Vergote I, Wu AH, Brenton JD, Pharoah PDP, Pearce CL, Pike MC, Goode EL, Ramus SJ, Köbel M, Nelson BH, DeFazio A, Friedlander ML, Bowtell DDL, Garsed DW

Nature communications2026Open Access

DOI: 10.1038/s41467-026-71134-3 PMID: 41922350

The real-world utility of homologous repair deficiency testing in BRCA1/2 wild-type high-grade serous carcinoma and the utility of MYC amplification as a potential surrogate marker

Radha Maradiya, Mary Kinloch, Antonio De Leo, Dario de Biase, Soufian El Hallani, Giovanni Tallini, Laura Hopkins, Mark S. Carey, Martin Köbel, Cheng-Han Lee, Christa Aubrey

Gynecologic Oncology2026Open Access

DOI: 10.1016/j.ygyno.2026.06.011 PMID: 42442041

PRRX1 -rearranged Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 18 Cases Including a Novel PRRX1::EP300 Fusion.

Dehner CA, Torres-Mora J, Thangaiah JJ, Oliveira A, Michal M, Malik F, Din NU, Hassan U, Maqbool H, Obeidin F, Caragea M, Lee CH, Schubart C, Agaimy A, Grundtmann B, Melchior L, Talman ML, Gross J, Cheah AL, Thway K, Fisher C, Antonescu CR, Linos K

The American journal of surgical pathology2026

DOI: 10.1097/pas.0000000000002472 PMID: 41036703

KAT6B/A::KANSL1 uterine sarcoma - A case with recurrences following uterine morcellation and the development of primary cell line model.

Chen L, Liu J, Nechala I, Praveen Kumar P, Ewanowich C, Levecchia M, Aubrey C, Fu Y, Lee CH

Gynecologic oncology reports2026Senior author

DOI: 10.1016/j.gore.2026.102168 PMID: 42502505

Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype

Marco Grillini, Jacopo Lenzi, Claudio Ceccarelli, Dario de Biase, Thais Maloberti, Sara Coluccelli, Laura Poppi, Riccardo Ciudino, Caterina Ravaioli, Camelia Alexandra Coadǎ, Gloria Ravegnini, Anna Myriam Perrone, Pierandrea De Iaco, Daniela Rubino, Claudio Zamagni, Benedetta Donati, Alessia Ciarrocchi, Sabrina Croce, Martin Köbel, Cheng‐Han Lee, Giovanni Tallini, Antonio De Leo

Histopathology20253 citationsOpen Access

DOI: 10.1111/his.15531 PMID: 40792549

GREB1 ‐rearranged uterine tumour shares a common DNA methylation signature with ESR1 ‐rearranged UTROSCT

Cheng‐Han Lee, Yow‐Shan Lee, Jennifer A. Bennett, David L. Kolin, Jen‐Chieh Lee, Hsuan‐Ying Huang, Martin Köbel, Mark Sementsov, Brendan Craig Dickson, Christian Koelsche, Friedrich Kommoss, Friedrich Kommoss, Andreas von Deimling, Felix K F Kommoss, Felix K F Kommoss

Histopathology20251 citationsFirst authorOpen Access

DOI: 10.1111/his.70075 PMID: 41424301

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Zwimpfer TA, Fereday S, Pandey A, Ariyaratne D, Jayawardana MW, Twomey L, Laumont CM, Kennedy CJ, Bolithon A, Meagher NS, Milne K, Hamilton P, Alsop J, Antoniou AC, Au-Yeung G, Beckmann MW, Berrington de Gonzalez A, Bisinotto C, Blome F, Bodelon C, Boros J, Brand AH, Carney ME, Cazorla-Jiménez A, Chiu DS, Christie EL, Chudecka-Głaz A, Coulson P, Cushing-Haugen KL, Cybulski C, Darcy KM, David C, Davidson T, Ekici AB, Elishaev E, Emons J, Engler T, Farrell R, Fischer A, García-Closas M, Gentry-Maharaj A, Ghatage P, Glasspool R, Harter P, Hartkopf AD, Hartmann A, Heikaus S, Hernandez BY, Hettiaratchi A, Heublein S, Huntsman DG, Jimenez-Linan M, Jones ME, Kang E, Kaznowska E, Kluz T, Kommoss FKF, Konecny G, Kruitwagen RFPM, Kwon J, Lambrechts D, Lee CH, Lester J, Leung SCY, Leung Y, Linder A, Lissowska J, Loverix L, Lubiński J, Mateoiu C, McNeish IA, Moubarak M, Nelson GS, Nevins N, Olawaiye AB, Olbrecht S, Orsulic S, Osorio A, Quinn CM, Mohan GR, Ray-Coquard I, Rodríguez-Antona C, Roxburgh P, Ruebner M, Salfinger SG, Samra S, Schoemaker MJ, Sinn HP, Sonke GS, Steele L, Stewart CJR, Talhouk A, Tan A, Tarney CM, Taylor SE, Van de Vijver KK, van der Aa MA, Van Gorp T, Van Nieuwenhuysen E, van-Wagensveld L, Wahner-Hendrickson AE, Walter C, Wang C, Welz J, Wentzensen N, Wilkens LR, Winham SJ, Winterhoff B, Anglesio MS, Berchuck A, Candido Dos Reis FJ, Cohen PA, Conrads TP, Crowe P, Doherty JA, Fasching PA, Fortner RT, García MJ, Gayther SA, Goodman MT, Gronwald J, Harris HR, Heitz F, Horlings HM, Karlan BY, Kelemen LE, Maxwell GL, Menon U, Modugno F, Neuhausen SL, Schildkraut JM, Staebler A, Sundfeldt K, Swerdlow AJ, Vergote I, Wu AH, Brenton JD, Pharoah PDP, Pearce CL, Pike MC, Goode EL, Ramus SJ, Köbel M, Nelson BH, DeFazio A, Friedlander ML, Bowtell DDL, Garsed DW

medRxiv : the preprint server for health sciences2025Open Access

DOI: 10.1101/2025.09.17.25335919 PMID: 41040691

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Cheng-Han Lee

Research

Latest papers

Latest funding

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor &#x3b1; Testing in Ovarian Cancer.

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-&#x3b3;.

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

The real-world utility of homologous repair deficiency testing in BRCA1/2 wild-type high-grade serous carcinoma and the utility of MYC amplification as a potential surrogate marker

PRRX1 -rearranged Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 18 Cases Including a Novel PRRX1::EP300 Fusion.

KAT6B/A::KANSL1 uterine sarcoma - A case with recurrences following uterine morcellation and the development of primary cell line model.

Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype

GREB1 ‐rearranged uterine tumour shares a common DNA methylation signature with ESR1 ‐rearranged UTROSCT

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Dissecting and targeting SWI/SNF loss in de-differentiated endometrial carcinomas

Linking Inactivating Mutations in Chromatin Remodeling Complex Subunits to Aggressive Dedifferentiated Endometrial Carcinoma

Translational research centre to target and characterize normal and cancer stem cell niches

Frequent collaborators

Martin Koebel

David Huntsman

Gregg Nelson

Aline Talhouk

Cyril Gilks

Basile Tessier-Cloutier

Michael Anglesio

Jessica Mcalpine

Yangxin Fu

Laura Hopkins

Sandra Lee

Lynne-Marie Postovit

Christa Aubrey

Mark Carey

Helen Steed

Mary Kinloch

Andrew Freywald

Anna Tinker

Zainab Al-Shamma

Marjan Rouzbahman

Brad Nelson

William Foulkes

Brendan Dickson

Sakinah Thiryayi

Valerie Dube

Arjumand Husain

Josee Ethier

Helen MacKay

Danielle Vicus

Patricia Shaw

Matthew Cesari

Blaise Clarke

Anand Krishnan

Shuk Leung

Aneesh Thakur

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.

Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.